LBRX MEXC RealStocks
Own real LBRX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 05:56:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
LB Pharmaceuticals Inc. (LBRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $42.52, with a market capitalization of $1.45B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.40 to $50.16. This page covers its latest market performance, valuation, price trends and company information.
$1.45B | |
$44.37 | |
$44.69 | |
$41.97 | |
$44.71 | |
387.75K | |
360.88K | |
-- | |
$50.16 | |
$14.40 | |
-- | |
-- |
LB Pharmaceuticals Inc. (LBRX) last closed at $42.52 as of 2026-11-13 00:31:00, down 5.03% ($2.25) from the previous close of $44.71.
During the latest regular trading session, LBRX traded between $41.97 and $44.69, with a volume of 387.75K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, LB Pharmaceuticals Inc. (LBRX) moved from $40.33 to $42.52, representing a gain of 5.43% ($2.19).
The stock traded between $37.99 and $45.78 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 376.91 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 78.6%
LBRX is currently trading at $42.52, placing it 78.6% of the way from its 52-week low of $14.40 to its 52-week high of $50.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 27 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for LB Pharmaceuticals Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of LB Pharmaceuticals Inc. (LBRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to LBRX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between LBRX shares and USD.
LBRX Shares to USD
1.00 LBRX shares = 42.52 USD
Calculations are estimates based on the latest available price and are for reference only.